Updated
VerastemVSTM · Healthcare
$8.41-10.34%
Market cap$794M
IndustryBiotechnology

Verastem (VSTM) Superinvestor holders

7 of the superinvestors we track hold Verastem (VSTM) in their latest 13F filings, $22M in total.

Summary

The largest holder is Wilmot Harkey (Nantahala Capital Management), with $14M, 0.8% of the portfolio.

In their latest quarter: 2 added, 4 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Wilmot Harkey
Nantahala Capital Management
Held 3,584,820$14M 0.8%Q2 2026
Robert Torray
Torray Investment Partners
Trimmed 464,381$4M 0.5%Q3 2026
Cliff Asness
AQR Capital Management
Added 934,565$4M 0.0%Q2 2026
Alan Howard
Brevan Howard
Added 72,383$276,141 0.0%Q2 2026
Man Group
Man Group plc
Trimmed 67,597$258,221 0.0%Q2 2026
Two Sigma
Two Sigma Investments
Trimmed 49,954$190,824 0.0%Q2 2026
Ken Tropin
Graham Capital Management
Trimmed 40,131$153,300 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 20267
Q1 20268
Q4 20259
Q3 20256
Q2 20256
Q1 20254
Q4 20244
Q3 20244

Questions about Verastem

Which superinvestors own Verastem?

7 of the superinvestors we track hold Verastem (VSTM) in their latest 13F filings, $22M in total. Wilmot Harkey, Robert Torray, Cliff Asness, Alan Howard, Man Group, Two Sigma.

Who is the largest superinvestor holder of VSTM?

The largest holder is Wilmot Harkey (Nantahala Capital Management), with $14M, 0.8% of the portfolio.

From Verastem's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Verastem and thousands of other companies, in one place. Free to start.